MENU
ATHA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Athira Pharma (ATHA) Earnings Date & Reports

Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration... Show more

A.I. Advisor
published Earnings

ATHA is expected to report earnings to fall 14.83% to -15 cents per share on November 06

Athira Pharma ATHA Stock Earnings Reports
Q3'25
Est.
$-0.15
Q2'25
Beat
by $0.04
Q1'25
Missed
by $0.05
Q4'24
Est.
$-0.38
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 9.27K shares outstanding, the current market capitalization sits at 15.30M.
View a ticker or compare two or three
ATHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ATHA showed earnings on August 07, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
18706 North Creek Parkway
Phone
+1 425 620-8501
Employees
67
Web
https://www.athira.com